Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Name: Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
SKU: 3053
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 4 Articles Tags: antidepressant, bipolar-disorder, carlos-a-zarate, depression, felbamate, glutamate, husseini-k-manji, jennifer-payne, jorge-quiroz, medworks-media, memantine, mood-stabilizer, nmdaampakainate, psychopharmacology-bulletin, riluzole

Description

Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Description

Carlos A. Zarate, MD

TRANSLATIONAL NEUROSCIENCE

Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Carlos A. Zarate, MD, Jorge Quiroz, MD, Jennifer Payne, MD, and Husseini K. Manji, MD

Clozapine Related Suicidal Obsession by Branka Aukst-Margetic

Antipsychotics Case Study by Yuan-Hwa Chou

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa

Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Description

Carlos A. Zarate, MD

TRANSLATIONAL NEUROSCIENCE

Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders

Carlos A. Zarate, MD, Jorge Quiroz, MD, Jennifer Payne, MD, and Husseini K. Manji, MD

Related products

Clozapine Related Suicidal Obsession by Branka Aukst-Margetic

Antipsychotics Case Study by Yuan-Hwa Chou

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa